ARS Pharmaceuticals (SPRY)
Maker of the first FDA-approved needle-free nasal spray for severe allergic reactions.
$4.23
vs last close−0.25 (−5.69%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 91.67% | 91.16M shares | |
|---|---|---|---|
| 217 holders · as of Jun 30, 2026 | |||
| Insiders | 21.08% | 20.97M shares | |
| 8 holders · as of Jun 12, 2026 | |||
| Adds to | 112.75% | ||
99.45M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 112.75%; nothing is left for Other.
13F, as of Jun 30, 2026
217 holders · 91.16M shares · 41 new positions · 116 increased · 54 reduced · 32 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 10.86M | 10.92% | 0 | Aug 14, 2026 |
| Rubric Capital Management LP | 8.54M | 8.59% | +540.9K | Aug 14, 2026 |
| Orbimed Advisors LLC | 8.29M | 8.33% | 0 | Aug 14, 2026 |
| Deerfield Management Company, L.P. (Series C) | 7.50M | 7.55% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 5.31M | 5.34% | +299.1K | Aug 7, 2026 |
| Tyro Capital Management LLC | 4.46M | 4.48% | +1.49M | Aug 13, 2026 |
| Abrdn PLC | 4.17M | 4.19% | +57.0K | Jul 31, 2026 |
| Sr One Capital Management, LP | 4.01M | 4.04% | 0 | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RA Capital Management, L.P.incl. RA Capital Healthcare Fund, L.P., Peter Kolchinsky +1 more | 11.10% | 10.94M | 13D | Oct 1, 2025 |
| Rubric Capital Management LP | 8.06% | 8.00M | 13G | May 15, 2026 |
| Deerfield Management Company, L.P.incl. Deerfield Mgmt III, L.P., Deerfield Private Design Fund III, L.P. +3 more | 7.75% | 7.61M | 13D | Aug 1, 2025 |
| Millennium Management LLC | 5.40% | 5.39M | 13G | Mar 24, 2026 |
| BlackRock, Inc. | 5.30% | 5.22M | 13G | Jul 27, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 12, 2026 | Alexander A. Fitzpatrickofficer: Chief Legal Officer | Sale | 3,355 | $10.00 | 90,910 |
| Jun 12, 2026 | Eric Karasofficer: Chief Commercial Officer | Sale | 25,000 | $10.00 | 12,176 |
| Nov 12, 2025 | Justin Chakmaofficer: Chief Business Officer | Sale · 2 lots | 166,380 | $8.87 | 0 |
| Nov 13, 2025 | Brian Dorseyofficer: Chief Operating Officer | Sale | 21,828 | $8.71 | 10,789 |
House and Senate disclosures
Not reported.